HAP Trading’s Array Biopharma Inc ARRY Stock Holding History

HAP Trading’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-20,800	Closed	-$418K	–	1577
2019 Q2	$418K	Buy	20,800 +4,400	+27%	+$124K	0.03%	365
2019 Q1	$68K	Buy	+16,400	New	+$341K	0.01%	613
2015 Q4	–	Sell	-60,100	Closed	-$11K	–	1205
2015 Q3	$11K	Sell	60,100 -340,000	-85%	-$2.02M	﹤0.01%	883
2015 Q2	$90K	Buy	400,100 +210,100	+111%	+$1.55M	0.01%	587
2015 Q1	$518K	Buy	+190,000	New	+$1.35M	0.04%	340

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

HAP Trading's ARRY Position: Q2 2018 in Review

HAP Trading sold out of Array Biopharma Inc (ARRY) in Q2 2018, closing a stake of 110,000 shares — an estimated $1.79M sold.

HAP Trading first reported a position in ARRY in Q1 2017 and held it in 3 quarters. The position peaked at $1.79M in Q1 2018. 223 funds tracked by Wall St. Rank hold ARRY as of Q2 2018.

HAP Trading reported no remaining Array Biopharma Inc position as of Q2 2018 after selling out during the quarter.
HAP Trading sold 110,000 Array Biopharma Inc shares in Q2 2018, an estimated $1.79M.
HAP Trading first reported a position in Array Biopharma Inc in Q1 2017 and held it in 3 quarters.
HAP Trading's Array Biopharma Inc position peaked at $1.79M in Q1 2018.
223 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q2 2018.

Based on HAP Trading's 13F filing for Q2 2018, filed 13 Aug 2018.